Picard Medical

PMI

Market cap $13.3M

NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Picard Medical, Inc. (NYSE American: PMI) breached their fiduciary duties to shareholders.

Vancouver, British Columbia--(Newsfile Corp. - June 25, 2026) - Perseverance Metals Inc. (TSXV: PMI) ("Perseverance", "PMI" or the "Company") is pleased to announce that its Board of Directors has appointed Isabelle Cadieux as an Independent Director, effective immediately. Ms. Cadieux, a Professional Geologist in the province of Québec, has over 35 years of experience in mineral exploration and the mining sector in both technical and financial roles, including serving for over 20 years as the Managing Director, Investment at SIDEX - a Québec institutional fund focused on exploration-stage companies in the province.

TUCSON, Ariz., June 24, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard Medical” or the “Company”), parent company of SynCardia Systems, LLC (“SynCardia”), maker of the world's first total artificial heart approved by both the U.S. Food and Drug Administration and Health Canada, today announced a leadership transition.

MINNEAPOLIS--(BUSINESS WIRE)--Eric Levine has joined U.S. Bank to lead the bank's strategy to deliver more connected treasury, payments and merchant solutions to healthcare organizations. As head of healthcare for Payments: Merchant and Institutional (PMI) Sales Distribution, Levine will advance the company's focus on aligning cross-bank teams to deliver tailored solutions to the healthcare industry, including hospital systems, payers, medical device manufacturers and life sciences companies. L.

STAMFORD, CT--(BUSINESS WIRE)--Philip Morris International (PMI) (NYSE: PM) and WSJ Intelligence, the in-house thought leadership consultancy for The Wall Street Journal's commercial sales organization, today revealed topline findings from a forthcoming study at Journal House during the Cannes Lions International Festival of Creativity. The study delivered a clear takeaway for global businesses: human cognition must be the absolute forefront of the modern corporate landscape. The findings show.

TUCSON, Ariz., June 16, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard Medical” or the “Company”), parent company of SynCardia Systems, LLC (“SynCardia”), maker of the world's first total artificial heart approved by both the U.S. Food and Drug Administration and Health Canada, today announced that SynCardia researchers will present new preclinical data from the Company's next generation Emperor Total Artificial Heart program and new clinical outcomes research involving patients supported with the SynCardia Total Artificial Heart at the American Society for Artificial Internal Organs (ASAIO) 2026 Annual Conference, taking place June 18-21, 2026, in New Orleans, Louisiana.

NEW YORK, June 9, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Picard Medical Inc. (NYSE AMERICAN: PMI) breached their fiduciary duties to shareholders.  According to a federal securities lawsuit, Insiders at Picard Medical caused the company to misrepresent or fail to disclose that (1) Picard was the subject of a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals; (2) that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign; and (3) Picard's public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity driving the stock price.

NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Picard Medical Inc. (NYSE American: PMI) breached their fiduciary duties to shareholders.

New York, New York--(Newsfile Corp. - June 3, 2026) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Picard Medical Inc. (NYSE American: PMI) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Picard Medical caused the company to misrepresent or fail to disclose that (1) Picard was the subject of a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals; (2) that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign; and (3) Picard's public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity driving the stock price.

— Independent dual motor ventricular design demonstrates stable full circulatory support across all study procedures —